Study of IBR733 Cell Injection in Acute Myeloid Leukemia
NCT06234904
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL:
IBR733 Cell Injection
Sponsor
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Collaborators
[object Object]